CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-11 | Duraibabu Prathyusha SVP, Chief Financial Officer | Shares withheld for taxes | −864 | $1.19 | $1K | 133,663 |
| 2023-06-01 | Smith Karen L. Director | Grant or award | +13,900 | 52,100 | ||
| 2023-06-01 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | PARKER H STEWART Director | Grant or award | +13,900 | 62,600 | ||
| 2023-06-01 | PARKER H STEWART Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Meyers James R Director | Grant or award | +13,900 | 49,600 | ||
| 2023-06-01 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Markels John Director | Grant or award | +13,900 | 46,384 | ||
| 2023-06-01 | Markels John Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Horn Margaret A Director | Grant or award | +13,900 | 32,650 | ||
| 2023-06-01 | Horn Margaret A Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Hillan Kenneth J. Director | Grant or award | +13,900 | 49,600 | ||
| 2023-06-01 | Hillan Kenneth J. Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Carey Robert Director | Grant or award | +13,900 | 49,600 | ||
| 2023-06-01 | Carey Robert Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-06-01 | Beers Courtney Director | Grant or award | +13,900 | 32,650 | ||
| 2023-06-01 | Beers Courtney Director | Grant or award · Stock Option (Right to Buy) | +27,750 | 27,750 | ||
| 2023-05-25 | Willoughby Scott B. SVP, Gen. Counsel & Secretary | Shares withheld for taxes | −1,328 | $1.33 | $2K | 125,284 |
| 2023-05-25 | Ramelmeier Rolf Andrew EVP, Technical Operations | Shares withheld for taxes | −1,750 | $1.33 | $2K | 171,467 |
| 2023-05-25 | McClung David Mark EVP, Chief Operating Officer | Shares withheld for taxes | −1,925 | $1.33 | $3K | 222,849 |
Page 10 of 17 · 338 trades